- Home
- BHC vs LU Comparison
BHC vs LU Comparison
Compare BHC & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHC | LU |
|---|---|---|
| Founded | N/A | 2005 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BHC | LU |
|---|---|---|
| Price | $6.52 | $1.21 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $8.00 | $2.00 |
| AVG Volume (30 Days) | ★ 3.7M | 983.6K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 423.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,724,000,000.00 | N/A |
| Revenue This Year | $4.61 | N/A |
| Revenue Next Year | N/A | $22.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.33 | $1.20 |
| 52 Week High | $8.00 | $4.57 |
Technical Indicators
Market Signals| Indicator | BHC | LU |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 33.72 |
| Support Level | $5.42 | $1.20 |
| Resistance Level | $7.24 | $1.45 |
| Average True Range (ATR) | 0.30 | 0.07 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 44.44 | 1.33 |
Price Performance
Historical ComparisonAbout BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
About LU Lufax Holding Ltd each representing two (2)
Lufax Holding Ltd is an investment holding company, together with its consolidated subsidiaries, engaged in core retail credit and enablement business to both borrowers and institutions in the People's Republic of China. The group's segments are Lending-related business, which provides Retail credit and enablement, consumer finance loans, and Digital banking business, including Retail banking and SME banking.